Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases
Michiel Simons1, Iris D Nagtegaal, Lucy I Overbeek
1Departments of Pathology (M.S., I.D.N., U.F., J.B.) Obstetrics and Gynecology (L.F.M.), Radboud University Nijmegen Medical Centre, Nijmegen PALGA Foundation (L.I.O.), Utrecht, The Netherlands.
Abstract:
We describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases 4 yr later. This was confirmed by an identical mutation in TP53 in both tumors. Metastases of ovarian borderline tumors outside the pelvis or abdominal cavity are extremely rare. A large epidemiologic search in the Dutch Pathology Registry that was conducted in support of this case, identifying 1812 intestinal-type mucinous ovarian borderline tumors, suggests that microinvasion is associated with a higher risk of disease spread. Our case illustrates that intestinal-type mucinous ovarian borderline tumor with intraepithelial carcinoma might also have a higher risk of metastasis, assuming that microinvasion occurs in the presence of intraepithelial carcinoma. Both intraepithelial carcinoma and microinvasion could be a trigger for more extensive tumor sampling to prevent sampling error of (micro)invasive adenocarcinoma. In addition, this case draws attention to the developmental spectrum of Types I and II ovarian carcinomas. Borderline tumors harboring a TP53 mutation require further studying to examine whether they might develop into high-grade Type II carcinomas.

